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GTP-binding proteins of the rab family are believed to function at several steps in intracellular vesicular transport. We examined the effects of 
a rab-related peptide in permeabilized pituitary cells, in which exocytosis can be triggered by distinct Ca2+-dependent or Ca:+-independent pathways. 
We report hat a synthetic peptide of 18 amino acids related to the rab effector domain, rab3AL(30~,7) inhibited luteinizing hormone (LH) and 
growth hormone (GH) exocytosis triggered by either pathway. Ca:+-stimulated LH and GH release were inhibited by more than 80% and 50%, 
respectively, by 100 ,uM peptide. The peptide (100/~M) also inhibited LH and GH exocytosis stimulated by phorbol myristate acetate plus cAMP 
by more than 45% and 80%, respectively. The effect was sequence-specific s nce a second peptide, lacking the first 3 amino acids but otherwise 
identical failed to inhibit exocytosis. These results uggest that a protein of the rab family is involved in regulated pituitary hormone xocytosis, 
and they identify 3 amino acids of the putative rab effector domain which may be functionally important in exocytosis. 
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1. INTRODUCTION 
The effects of hydrolysis-resistant GTP analogs in a 
variety of secretory cell types have provided evidence 
that GTP-binding proteins are involved in regulated 
exocytosis at a site distal to second messenger genera- 
tion [1 9]. The identity of these protein(s) is unclear, 
and GTP-binding proteins belonging to both the 
heterotrimeric and the small monomeric lasses are re- 
ported to be associated with secretory vesicles [10]. 
The rab family of small GTP-binding proteins are 
known to be involved at several stages in vesicular 
transport in mammalian cells [11,12]. In constitutive 
exocytosis in yeast, a monomeric GTP-binding protein, 
SEC4p, functions in the targeting or fusion of secretory 
vesicles with the plasma membrane [13]. Rab3a appears 
to be a likely candidate for a similar role in regulated 
exocytosis in mammalian cells, because of its associa- 
tion with synaptic vesicles and its dissociation during 
exocytosis [14,15]. Although this is an attractive hy- 
pothesis, functional studies are needed to confirm the 
involvement of a rab-related protein in either constitu- 
tive or regulated exocytosis in mammalian cells. 
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We report here that in permeabilized pituitary cells, 
exocytosis of luteinizing hormone (LH) and growth 
hormone (GH) stimulated by both Ca2+-dependent a d 
CaZ+-independent mechanisms was inhibited by a syn- 
thetic peptide related in sequence to the rab effector 
domain. 
2. MATERIALS AND METHODS 
Primary sheep pituitary cells were dispersed with collagenase and 
cultured in 12-well plates for 48h as previously described [16]. At- 
tached cells were washed twice with HEPES-buffered saline (buffer I, 
ref. 16) and once in Ca2+-free buffer 1. Cells were incubated for 10 min 
with ice-cold buffer IC containing 0.5 mM EGTA, 1 mM MgCI 2 and 
1 U/ml streptolysin O (SLO, Wellcome Diagnostics cat. no. MR 16) 
to allow binding of SLO to cells. Buffer IC consisted of 140 mM Na 
propionate, 25 mM PIPES (pH 6.6). Excess SLO-containing buffer 
was removed and cells were permeabilized and stimulated simultane- 
ously by addition of 0.4 ml/well buffer IC at 37°C, containing 5 mM 
sodium ATE 10 mM creatine phosphate, 7 mM MgCI 2 and Ca-EGTA 
mixture (total EGTA 30 mM) formulated to give free Ca 2+ 0.1 /IM 
(unstimulated) or 10/IM (Ca2+-stimulated). An alternative stimulation 
utilized 0.1 HM phorbol myristate acetate (PMA) plus 30/IM cAME 
with 0.1 ,uM free Ca -~+. After 15 min the medium was collected, centri- 
fuged and stored at -20°C prior to assay for LH and GH. 
Ovine LH and GH were determined by radioimmunoassay using 
reagents provided by the National Institute for Diabetic, Digestive 
and Kidney Diseases, using the recommended procedures. Hormone 
release is expressed as% of total cellular hormone content determined 
after lysis of cells from 4 unstimulated (control) wells with 1% Triton 
X-100. Data points show the mean + difference of duplicate wells in 
a representative experiment. Each experiment was performed inde- 
pendently 2 to 4 times with similar results. 
The peptide nomenclature used follows that of Plutner et al. [17]. 
The numbering refers to the homologous amino acid positions in 
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Ha-ras. Peptides Rab3AL(3(? ~47) (PAFVSALGIDFKVKTIYR) and 
Rab3AL(33-47) (VSALGIDFKVKTIYR) were synthesized by the 
solid phase method using Boc for s-amino protection and benzyl- 
based protecting roups for side chain functional groups. Peptides 
were assembled on a Boc Arg (MTS) Pam resin using an Applied 
Biosystems Model 431A automated synthesizer, with couplings medi- 
ated by DCC/HOBt. After treatment of the resin with HF at 0°C for 
45 min the peptides were extracted into 50% HOAc, diluted with water 
and lyophilized to a white powder. Crude peptides were purified to 
homogeneity b  preparative r versed-phase chromatography on C~8 
silica gel, using isocratic elution with acetonitrile/water/0.1% TFA. 
3. RESULTS AND DISCUSSION 
Rab proteins contain a highly conserved region (ho- 
mologous to amino acids 33-48 in Ha-ras) which, by 
analogy with the ras proteins, is thought o be the effec- 
tor domain which mediates the functions of these pro- 
teins in vesicular transport [17]. It was recently reported 
that synthetic peptides related to the putative effector 
domain of the rab proteins inhibited endoplasmic retic- 
ulum to Golgi and intra-Golgi vesicular transport in 
cell-free assay systems [17]. The most potent inhibitory 
peptide in that study was rab3AL(33-48), which is de- 
rived from the rab3 sequence with two amino acid sub- 
stititions. We therefore chose a similar peptide, 
rab3AL(33-47) for the present study, together with a 
longer peptide, rab3AL(30-47). 
We previously showed that in permeabilized pituitary 
cells LH exocytosis can be stimulated by two distinct 
triggering mechanisms, (a) a CaZ+-dependent pathway 
maximally stimulated by 10 ¢tM free Ca 2+ and (b) a 
Ca2+-independent pathway maximally stimulated by a 
combination of the protein kinase C activator phorbol 
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Fig. 2. Effect of peptide rab3AL(30-47) on OH exocytosis stimulated 
by Ca 2+ (circles), phorbol ester plus cAMP (squares) orunstimulated 
(triangles). 
myristate acetate (PMA) plus cAMP [16,18]. The effect 
of rab-related peptides on both of these modes of stim- 
ulation was investigated in the present study. 
Peptide Rab3AL(30-47) inhibited both Ca 2+ and 
PMA/cAMP stimulation of LH and GH exocytosis in 
a dose-dependent manner (Figs. 1 and 2). The peptide 
had no effect on basal release of either hormone. At a 
concentration of 100 ¢tM, Ca2+-stimulated LH release 
was inhibited by more than 80% in all 4 experiments. 
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Fig. 1. Effect of peptide rab3AL(30-47) on LH exocytosis stimulated 
by Ca 2+ (circles), phorbol ester plus cAMP (squares) or unstimulated 
(triangles). 
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Fig. 3. Effect of peptide rab3AL(33~7) on LH exocytosis stimulated 
by Ca z÷ (circles), phorbol ester plus cAMP (squares) or unstimulated 
(triangles). 
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Fig. 4. Effect of peptide Rab3AL(3047) on GH exocytosis stimulated 
by Ca 2÷ (circles), phorbol ester plus cAMP (squares) or unstimulated 
(triangles). 
Inhibit ion of  PMA/cAMP-s t imu lated  LH release was 
more variable, ranging from 45% to 85% inhibit ion by 
100 ~tM peptide. The same concentrat ion of  peptide 
inhibited Ca2+-stimulated GH exocytosis by 50 to 100%, 
and PMA/cAMP-s t imu lated  GH exocytosis by 80 to 
100% (2 experiments). These concentrat ions of  peptide 
are in the same range as reported for inhibit ion of  ER 
to Golgi  and intra-Golgi  t ransport  by rab3AL(33M8)  
[171. 
In contrast,  the shorter peptide Rab3AL(33~7)  at 
concentrat ions up to 100 pM was without any effect on 
LH or GH release st imulated by either tr iggering path- 
way (Figs. 3 and 4). 
These results indicate that the inhibitory effect has an 
absolute requirement for the N-terminal  3 amino acids 
of  the longer peptide. Inhibit ion of  pituitary hormone 
exocytosis therefore requires a sequence specificity dif- 
ferent from that for inhibit ion of  ER to Golgi  and intra- 
Golgi  transport ,  since the latter processes were inhibited 
by rab3AL(33-48)  [17]. 
In two recent studies the peptide rab3AL(33~8)  was 
surprisingly found to enhance, rather than inhibit  regu- 
lated exocytosis in permeabi l ized pancreat ic acini [19], 
and chromaff in cells [20]. Peptides extending further in 
the N-terminal  direction were not examined in those 
studies, and it would therefore be of  interest o deter- 
mine whether ab3AL(3047)  also inhibits exocytosis in 
these cell types. 
In summary, a peptide related to the rab effector 
domain  inhibited exocytosis of  LH and GH triggered by 
Ca2+-dependent and Ca2+-independent pathways,  sug- 
gesting the involvement of  a rab-l ike protein in regu- 
lated exocytosis. A larger number of  peptides are cur- 
rently being examined in order to determine the precise 
sequence specificity of  the inhibitory effect. 
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